PURPOSE: Hyaluronan (HA) is a major component of the aqueous outflow pathway. However, the contribution of HA to human outflow resistance remains unclear. Three HA synthase genes (HAS1-3) have been identified. Here, we evaluate the contribution of each of the HAS proteins to outflow facility in anterior segment perfusion culture. METHODS: Two methods were used to reduce HA synthesis: 1 mM 4-methylumbelliferone (4MU) was used to inhibit all HAS synthases and shRNA silencing lentivirus was generated to knock down expression of each HAS individually. Quantitative RT-PCR, Western immunoblotting and an HA ELISA assay were used to assess HAS mRNA and protein levels and HA concentration, respectively. The effects of 4MU treatment and HAS gene silencing on outflow facility were assessed in human and porcine perfusion culture. RESULTS: Quantitative RT-PCR and Western immunoblotting showed a reduction of each HAS in response to their respective silencing and 4MU treatment. HA concentration was concomitantly reduced. Treatment with 4MU decreased outflow facility in human anterior segments but increased outflow facility in porcine eyes. Lentiviral delivery of HAS1 and HAS2 silencing vectors caused similar opposite effects on outflow facility. Silencing of HAS3 did not significantly affect outflow resistance in either species. CONCLUSIONS: This is the first conclusive evidence for a significant role of HA in the human outflow pathway. HA chains synthesized by HAS1 and HAS2 contribute to outflow resistance, while hyaluronan produced by HAS3 does not appear to play a significant role.
PURPOSE:Hyaluronan (HA) is a major component of the aqueous outflow pathway. However, the contribution of HA to human outflow resistance remains unclear. Three HA synthase genes (HAS1-3) have been identified. Here, we evaluate the contribution of each of the HAS proteins to outflow facility in anterior segment perfusion culture. METHODS: Two methods were used to reduce HA synthesis: 1 mM 4-methylumbelliferone (4MU) was used to inhibit all HAS synthases and shRNA silencing lentivirus was generated to knock down expression of each HAS individually. Quantitative RT-PCR, Western immunoblotting and an HA ELISA assay were used to assess HAS mRNA and protein levels and HA concentration, respectively. The effects of 4MU treatment and HAS gene silencing on outflow facility were assessed in human and porcine perfusion culture. RESULTS: Quantitative RT-PCR and Western immunoblotting showed a reduction of each HAS in response to their respective silencing and 4MU treatment. HA concentration was concomitantly reduced. Treatment with 4MU decreased outflow facility in human anterior segments but increased outflow facility in porcine eyes. Lentiviral delivery of HAS1 and HAS2 silencing vectors caused similar opposite effects on outflow facility. Silencing of HAS3 did not significantly affect outflow resistance in either species. CONCLUSIONS: This is the first conclusive evidence for a significant role of HA in the human outflow pathway. HA chains synthesized by HAS1 and HAS2 contribute to outflow resistance, while hyaluronan produced by HAS3 does not appear to play a significant role.
Authors: Francesca Pasutto; Kate E Keller; Nicole Weisschuh; Heinrich Sticht; John R Samples; Yong-Feng Yang; Matthias Zenkel; Ursula Schlötzer-Schrehardt; Christian Y Mardin; Paolo Frezzotti; Beth Edmunds; Patricia L Kramer; Eugen Gramer; André Reis; Ted S Acott; Mary K Wirtz Journal: Hum Mol Genet Date: 2011-12-08 Impact factor: 6.150
Authors: W C Hubbard; M Johnson; H Gong; B T Gabelt; J A Peterson; R Sawhney; T Freddo; P L Kaufman Journal: Exp Eye Res Date: 1997-08 Impact factor: 3.467
Authors: Anne Kultti; Sanna Pasonen-Seppänen; Marjo Jauhiainen; Kirsi J Rilla; Riikka Kärnä; Emma Pyöriä; Raija H Tammi; Markku I Tammi Journal: Exp Cell Res Date: 2009-03-13 Impact factor: 3.905
Authors: Kate E Keller; Janice A Vranka; Ramez I Haddadin; Min-Hyung Kang; Dong-Jin Oh; Douglas J Rhee; Yong-Feng Yang; Ying Ying Sun; Mary J Kelley; Ted S Acott Journal: Invest Ophthalmol Vis Sci Date: 2013-08-19 Impact factor: 4.799
Authors: Mini Aga; John M Bradley; Rohan Wanchu; Yong-feng Yang; Ted S Acott; Kate E Keller Journal: Invest Ophthalmol Vis Sci Date: 2014-08-07 Impact factor: 4.799